JP2022550640A5 - - Google Patents

Info

Publication number
JP2022550640A5
JP2022550640A5 JP2022546587A JP2022546587A JP2022550640A5 JP 2022550640 A5 JP2022550640 A5 JP 2022550640A5 JP 2022546587 A JP2022546587 A JP 2022546587A JP 2022546587 A JP2022546587 A JP 2022546587A JP 2022550640 A5 JP2022550640 A5 JP 2022550640A5
Authority
JP
Japan
Application number
JP2022546587A
Other languages
Japanese (ja)
Other versions
JP2022550640A (ja
JPWO2021071802A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054347 external-priority patent/WO2021071802A1/en
Publication of JP2022550640A publication Critical patent/JP2022550640A/ja
Publication of JP2022550640A5 publication Critical patent/JP2022550640A5/ja
Publication of JPWO2021071802A5 publication Critical patent/JPWO2021071802A5/ja
Priority to JP2025136895A priority Critical patent/JP2025186255A/ja
Withdrawn legal-status Critical Current

Links

JP2022546587A 2019-10-07 2020-10-06 Kv1.3カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物 Withdrawn JP2022550640A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025136895A JP2025186255A (ja) 2019-10-07 2025-08-20 Kv1.3カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962911670P 2019-10-07 2019-10-07
US62/911,670 2019-10-07
PCT/US2020/054347 WO2021071802A1 (en) 2019-10-07 2020-10-06 Aryl heterocyclic compounds as kv1.3 potassium shaker channel blockers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025136895A Division JP2025186255A (ja) 2019-10-07 2025-08-20 Kv1.3カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物

Publications (3)

Publication Number Publication Date
JP2022550640A JP2022550640A (ja) 2022-12-02
JP2022550640A5 true JP2022550640A5 (https=) 2024-09-10
JPWO2021071802A5 JPWO2021071802A5 (https=) 2024-09-10

Family

ID=75438323

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022546587A Withdrawn JP2022550640A (ja) 2019-10-07 2020-10-06 Kv1.3カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物
JP2025136895A Pending JP2025186255A (ja) 2019-10-07 2025-08-20 Kv1.3カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025136895A Pending JP2025186255A (ja) 2019-10-07 2025-08-20 Kv1.3カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物

Country Status (11)

Country Link
US (1) US20230026611A1 (https=)
EP (1) EP4041407A4 (https=)
JP (2) JP2022550640A (https=)
KR (1) KR20220079882A (https=)
CN (1) CN114746151A (https=)
AU (1) AU2020362108A1 (https=)
BR (1) BR112022006202A2 (https=)
CA (1) CA3156980A1 (https=)
IL (1) IL291868A (https=)
MX (1) MX2022004127A (https=)
WO (1) WO2021071802A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116782894A (zh) * 2020-10-06 2023-09-19 D.E.肖研究有限责任公司 作为Kv1.3钾Shaker通道阻断剂的内酰胺化合物
KR20230164136A (ko) * 2021-03-30 2023-12-01 디.이. 쇼우 리서치, 엘엘씨 Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로시클릭 화합물
AR125994A1 (es) * 2021-05-28 2023-08-30 De Shaw Res Llc COMPUESTOS DE ESPIROINDOLINONA COMO BLOQUEADORES DEL CANAL DE POTASIO Kv1.3
CN113637002B (zh) * 2021-08-02 2022-09-30 天津太平洋化学制药有限公司 一种尼拉帕尼的制备方法
CN113603573A (zh) * 2021-08-09 2021-11-05 苏州求索生物科技有限公司 一种3,5-二氯-2-碘苯甲醚的制备工艺
CN114213315A (zh) * 2021-12-31 2022-03-22 上海陶术生物科技有限公司 含氮杂环类化合物及其中间体的合成方法
CN114524800A (zh) * 2022-01-20 2022-05-24 上海陶术生物科技有限公司 尼拉帕尼中间体的合成方法
AU2023370498B2 (en) * 2022-10-28 2026-01-22 Shanghai Deep Potential Technology Co., Ltd. Aryl heterocyclic kv1.3 inhibitor, preparation method therefor, and use thereof
WO2025021167A1 (zh) * 2023-07-26 2025-01-30 上海汇伦医药股份有限公司 芳基含氮杂环化合物、药物组合物和应用
WO2025029769A1 (en) 2023-07-31 2025-02-06 Eli Lilly And Company Solid forms of a kv1.3 potassium shaker channel blockers and method of using the same
WO2025077671A1 (zh) * 2023-10-09 2025-04-17 浙江海正药业股份有限公司 多取代芳基类衍生物及其制备方法和用途
CN120383599A (zh) * 2024-01-29 2025-07-29 上海深势唯思科技有限责任公司 芳基杂环类Kv1.3抑制剂及其制备方法和用途
WO2026025999A1 (zh) * 2024-08-01 2026-02-05 浙江海正药业股份有限公司 6,7-二氢-5H-吡咯并[1,2-a]咪唑类衍生物及其制备方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950479A1 (de) * 1979-12-14 1981-06-19 A. Nattermann & Cie GmbH, 5000 Köln N-(3-alkylamino-2-hydroxypropoxy-phenyl)-lactame, deren herstellungsverfahren und arzneimitttel auf deren basis
JPH07309837A (ja) * 1993-04-28 1995-11-28 Takeda Chem Ind Ltd ピリジン誘導体、その製造法および剤
JPH09278757A (ja) * 1996-04-15 1997-10-28 Takeda Chem Ind Ltd ヒドラゾン誘導体および剤
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
CA2318814A1 (en) * 1998-01-29 1999-08-05 Xi Chen Benzoate derivatives of diaryl 1,3,4-oxadiazolone
WO2002055497A1 (en) * 2001-01-15 2002-07-18 Glaxo Group Limited Aryl piperidine derivatives as inducers of ldl-receptor expression
US7223788B2 (en) * 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
US7384930B2 (en) * 2004-11-03 2008-06-10 Bristol-Myers Squibb Company Constrained compounds as CGRP-receptor antagonists
JP2010540569A (ja) * 2007-10-04 2010-12-24 バイオノミックス リミテッド 新規アリールカリウムチャンネル遮断薬およびそれらの使用
GB0815784D0 (en) * 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0909672D0 (en) * 2009-06-04 2009-07-22 Xention Discovery Ltd Compounds
WO2011073269A1 (en) * 2009-12-16 2011-06-23 Evotec Ag Piperidine aryl sulfonamide derivatives as kv1.3 modulators
WO2017058716A1 (en) * 2015-09-28 2017-04-06 Vivace Therapeutics, Inc. Tricyclic compounds
GB201610056D0 (en) * 2016-06-09 2016-07-27 Galapagos Nv And Laboratoires Servier Les Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
GB201610055D0 (en) * 2016-06-09 2016-07-27 Galapagos Nv And Laboratoires Servier Les Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
CN109705033B (zh) * 2019-01-22 2021-03-30 杭州壹瑞医药科技有限公司 N-杂芳基磺酰胺类衍生物及制备和应用

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022550640A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)